Literature DB >> 2642484

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.

A H Danser1, M A van den Dorpel, J Deinum, F H Derkx, A A Franken, E Peperkamp, P T de Jong, M A Schalekamp.   

Abstract

Renin, prorenin, and immunoreactive renin were present in vitreous and subretinal fluid of eyes from subjects with and without diabetic retinopathy. Renin substrate, albumin, transferrin, and immunoglobin G were also found in these ocular fluids. In many samples renin levels were close to the detection limit of the assay. The levels of renin substrate, albumin, transferrin, and immunoglobulin G varied widely among ocular fluid samples, but in each individual sample the levels were, relative to each other, similar to those in plasma. In contrast, the prorenin level in ocular fluid was up to 100 times higher than expected on the basis of the plasma protein content of ocular fluid. Moreover, there was little difference in prorenin concentrations between samples with low and high plasma protein contents. Prorenin, relative to albumin and other plasma proteins, was higher in vitreous fluid from eyes with proliferative diabetic retinopathy complicated by traction retinal detachment than in eyes of nondiabetic subjects with spontaneous retinal detachment. It appears that prorenin (and possibly renin) in ocular fluid is controlled by an active and specific process, possibly local synthesis within the eye. In view of the vascular actions of angiotensin II, an intraocular renin-angiotensin system may play a role in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642484     DOI: 10.1210/jcem-68-1-160

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  58 in total

1.  Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?

Authors:  Norman K Hollenberg; Naomi D L Fisher; Juerg Nussberger; George V Moukarbel; Ebrahim Barkoudah; A H Jan Danser
Journal:  J Hypertens       Date:  2011-12       Impact factor: 4.844

Review 2.  Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida; Carlos M Ferrario; Sarfaraz Ahmad
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

3.  Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.

Authors:  J L Wilkinson-Berka; G Tan; K J Binger; L Sutton; K McMaster; D Deliyanti; G Perera; D J Campbell; A G Miller
Journal:  Diabetologia       Date:  2011-07-14       Impact factor: 10.122

Review 4.  Aliskiren: the first direct renin inhibitor for hypertension.

Authors:  Anton H van den Meiracker; A H Jan Danser
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 5.  Prorenin and the (pro)renin receptor in ocular pathology.

Authors:  Jennifer L Wilkinson-Berka
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

Review 6.  Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin.

Authors:  Manne Krop; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

7.  The renin-angiotensin system in the human eye.

Authors:  N J Van Haeringen
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

8.  Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

Authors:  S Mäkimattila; P Summanen; I Matinlauri; M Mäntysaari; A Schlenzka; M Aalto; K Irjala; H Yki-Järvinen
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

9.  Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

Authors:  J Wagner; A H Jan Danser; F H Derkx; T V de Jong; M Paul; J J Mullins; M A Schalekamp; D Ganten
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

10.  Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition.

Authors:  A A Dosso; E Rungger-Brändle; P M Leuenberger
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.